Search results
Results from the WOW.Com Content Network
Jennifer Doudna was born February 19, 1964, in Washington, D.C., as the daughter of Dorothy Jane (Williams) and Martin Kirk Doudna. [2] [17] Her father received his PhD in English literature from the University of Michigan, and her mother held a master's degree in education.
By using CRISPR technology, they aimed to "knock out" this gene in the muscle cells of their forearm. The intent was to disrupt the gene's function, potentially allowing for localized muscle growth. [14] [15] [16] Zayner's CRISPR kit was displayed at the Cooper Hewitt's 2019 Nature Design Triennial. [17]
He co-developed Multiplex Automated Genome Engineering (MAGE) and optimized CRISPR/Cas9, discovered by Jennifer Doudna and Emmanuelle Charpentier for engineering a variety of genomes ranging from yeast to human. [62] His laboratory's use of CRISPR in human induced pluripotent stem cells (hiPS) is the latest contender for precise gene therapy. [64]
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland.It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases.
Rodolphe Barrangou is the Todd R. Klaenhammer Distinguished Professor in Probiotics Research in the Department of Food, Bioprocessing and Nutrition Sciences at North Carolina State University; Co-Founder and Chief Executive Officer of CRISPR Biotechnologies; Co-Founder and Chief Scientific Officer of Ancilia Biosciences; Co-Founder, President and Chief Scientific Officer of TreeCo; and Co ...
Federal prosecutors have charged the founder of an education-technology startup spun out of Harvard who was recognized on a 2021 Forbes 30 Under 30 list with fraud.
Qi obtained his B.S. in physics and math from Tsinghua University, [1] China, Master in physics from UC Berkeley, and PhD in bioengineering from UC Berkeley. [2] During his PhD work at Berkeley, he studied synthetic biology with Adam Arkin, and was the first to explore engineering the CRISPR for targeted gene editing and gene regulation with Jennifer Doudna. [3]
Feng Zhang (Chinese: 张锋; pinyin: Zhāng Fēng; born October 22, 1981) is a Chinese–American biochemist.Zhang currently holds the James and Patricia Poitras Professorship in Neuroscience at the McGovern Institute for Brain Research and in the departments of Brain and Cognitive Sciences and Biological Engineering at the Massachusetts Institute of Technology.